{"title":"A Severe Form of Pediatric Visceral Leishmaniasis - A Case Report","authors":"Vardan Gevorgyan Nazeli, Valeri Apresyan Hripsime","doi":"10.23937/2643-461x/1710048","DOIUrl":null,"url":null,"abstract":"According to the World Health Organization, leishmaniasis is one of the seven most important tropical diseases, and it is a major global health concern. In Armenia, it is a re-emerging disease. We present a case of a one-year-old child from active visceral leishmaniasis (VL) focus with a history of intermittent fever and anemia, progressive weakness, abdominal distension with loss of appetite for 3 months. The case was confirmed as VL by a positive result for the rK39 test. Considering the symptoms and signs a combination of VL and secondary hemophagocytic lymphohistiocytosis (HLH) was suspected. The patient was treated with a 21 mg/kg total dose of AmBisome. The child responded positively to treatment, and HLH syndrome was excluded.","PeriodicalId":121181,"journal":{"name":"International Journal of Tropical Diseases","volume":"24 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Tropical Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/2643-461x/1710048","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
According to the World Health Organization, leishmaniasis is one of the seven most important tropical diseases, and it is a major global health concern. In Armenia, it is a re-emerging disease. We present a case of a one-year-old child from active visceral leishmaniasis (VL) focus with a history of intermittent fever and anemia, progressive weakness, abdominal distension with loss of appetite for 3 months. The case was confirmed as VL by a positive result for the rK39 test. Considering the symptoms and signs a combination of VL and secondary hemophagocytic lymphohistiocytosis (HLH) was suspected. The patient was treated with a 21 mg/kg total dose of AmBisome. The child responded positively to treatment, and HLH syndrome was excluded.